BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series. This multipart special ...
Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a leading ...
This acquisition strengthens Mubadala's portfolio of biologicals, establishes its role in biomanufacturing across the MENA region ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback